FDA Approves Itovebi
On October 10, 2024, the FDA approved inavolisib (ItovebiTM, Genentech, Inc.) with palbociclib (Ibrance®) and fulvestrant (Faslodex®) and a companion diagnostic...
Read More PAST ARTICLES
2024
2023
2022
2021
SEARCH OUR SITE
for past articles or specific information.